Prosecution Insights
Last updated: July 17, 2026
Application No. 19/232,563

Duodenal Ablation with Improved Depth and Consistency of Ablation

Non-Final OA §112
Filed
Jun 09, 2025
Priority
Jun 01, 2018 — provisional 62/679,694 +7 more
Examiner
SHOULDERS, ANNIE LEE
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Aqua Medical, Inc.
OA Round
3 (Non-Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
2y 5m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
144 granted / 196 resolved
+3.5% vs TC avg
Strong +18% interview lift
Without
With
+18.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
38 currently pending
Career history
238
Total Applications
across all art units

Statute-Specific Performance

§103
86.3%
+46.3% vs TC avg
§102
1.0%
-39.0% vs TC avg
§112
2.5%
-37.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 196 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Continued Examination Under 37 CFR 1.114 3. A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 04/23/2026 has been entered. Claim Rejections - 35 USC § 112 4. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. 5. Claims 1, 6, 10, 16, and 17, as well as claims 2-5, 7-9, 12-15, 18-29, and 31 due to their dependencies on the previous claims, are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. 6. Claim 1 recites the limitation "the distal end of the catheter" in lines 7-8 and 12-13. There is insufficient antecedent basis for this limitation in the claim. While Claim 1 does recite “a catheter” in line 3 of the claim, there is no recitation of “a distal end” of the catheter. Therefore, the claim is indefinite. Proper correction is required. 7. Claims 6, 10, 16, and 17 all recite the limitation “the distal end of the catheter”. Since Claim 1 fails to recite “a distal end of the catheter”, this renders these claims indefinite. Proper correction is required. Allowable Subject Matter 8. Claim 1 contains allowable subject matter. The following is a statement of reasons for the indication of allowable subject matter: a method of ablating tissue comprising inserting an endoscope, inserting a catheter through a channel of the endoscope, and expanding a structure to circumferentially surround an interior surface of the target tissue is well known in the art. This is supported by at least the references cited during the prosecution of this case, as well as other references in the general area that could be located with minimal effort. However, the prior art of record fails to specifically teach directing a first amount of energy to a first treatment zone, compressing the structure, directing a second amount of energy to a second treatment zone, and after directing the second amount of energy to the second treatment zone, repeatedly moving the catheter to different portions of the patient's duodenum, forming different treatment zones, and applying amounts of energy until a contiguous circumferential ablation region comprising of 25% to 90% of the patient's mucosa over a length of 2 cm to 25 cm of the duodenum is achieved, wherein said circumferential ablation region is defined by ablated tissue having an average thickness and a mean thickness and wherein a thickness of ablated tissue at any specific point in the circumferential ablation region is within 25% of said average thickness or mean thickness. The prior art also fails to provide sufficient motivation to make such specific modifications and would require improper use of hindsight to arrive at the claimed invention when considered along or in any proper combination. 9. As allowable subject matter has been indicated, applicant's reply must either comply with all formal requirements or specifically traverse each requirement not complied with. See 37 CFR 1.111(b) and MPEP § 707.07(a). Conclusion 10. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANNIE L SHOULDERS whose telephone number is (571)272-3846. The examiner can normally be reached Monday-Friday (alternate Fridays) 8AM-5PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at 571-272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANNIE L SHOULDERS/Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Jun 09, 2025
Application Filed
Aug 14, 2025
Non-Final Rejection mailed — §112
Dec 15, 2025
Response Filed
Jan 26, 2026
Final Rejection mailed — §112
Apr 23, 2026
Request for Continued Examination
Apr 30, 2026
Response after Non-Final Action
May 28, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678223
SYSTEMS AND METHODS FOR CYLINDRICAL CAGE MAPPING AND ABLATION CATHETERS HAVING FLEXIBLE CIRCUITS
2y 8m to grant Granted Jul 14, 2026
Patent 12678327
CAPSULOTOMY DEVICE
2y 7m to grant Granted Jul 14, 2026
Patent 12643111
NANO SURFACES ON SMOKE PARTICLE ELECTRODES
3y 7m to grant Granted Jun 02, 2026
Patent 12642573
ELECTROSURGICAL SYSTEM WITH ELECTRODE ASSEMBLY AND ACCESSORY CHARGE CIRCUIT
2y 5m to grant Granted Jun 02, 2026
Patent 12642568
Duodenal Ablation with Improved Depth and Consistency of Ablation
2y 3m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
92%
With Interview (+18.5%)
3y 7m (~2y 5m remaining)
Median Time to Grant
High
PTA Risk
Based on 196 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month